Product Program year 2025 Source: CMS Open Payments

Alloderm

Device Plastic Surgery

Open in the dashboard

General payments

$51,332,611

15,276 payments

Research payments

$115,410

13 payments

Through program year 2025, $51,332,611 in general payments and $115,410 in research payments were reported against Alloderm (Plastic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

11 rows
Year Kind Amount Payments
2025 General $7,588,614 3,782
2024 General $7,401,138 3,519
2023 General $11,845,865 3,130
2022 General $22,303,451 106
2022 Research $27,170 1
2021 General $707 33
2021 Research $2,128 2
2020 General $211,440 111
2020 Research $30,000 1
2019 General $1,981,395 4,595
2019 Research $56,112 9

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $49,073,402 10,433 payments
  2. Allergan Inc. $2,259,209 4,843 payments
Top recipients General payments · program year 2025
  1. George Maxwell Plastic Surgery · Nashville, TN $7,190,966 95% · 4 payments
  2. Maurice Nahabedian Plastic and Reconstructive Surgery · Mc Lean, VA $22,551 <1% · 2 payments
  3. John Apostolides Plastic Surgery · San Diego, CA $15,593 <1% · 9 payments
  4. Michael Edwards Plastic Surgery · Las Vegas, NV $15,330 <1% · 19 payments
  5. Kelly Killeen Plastic Surgery · Beverly Hills, CA $15,123 <1% · 16 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $7,360,363 98% · 500 practitioners
  2. Plastic and Reconstructive Surgery Surgery $78,974 1% · 336 practitioners
  3. Surgery $22,105 <1% · 121 practitioners
  4. Physician Assistant $16,658 <1% · 107 practitioners
  5. Rheumatology Internal Medicine $14,400 <1% · 1 practitioner

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Tennessee $7,193,838 95% · 27 recipients
  2. California $71,391 <1% · 160 recipients
  3. Texas $44,058 <1% · 194 recipients
  4. New York $31,675 <1% · 120 recipients
  5. Florida $30,573 <1% · 142 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

15,276 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record